|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$394.72 |
$396.98 |
$391.25 |
$394.28 |
1.34M | 04/22/2024 |
$397.30 |
$406.34 |
$396.00 |
$399.92 |
1.39M | 04/23/2024 |
$404.00 |
$406.86 |
$403.47 |
$404.91 |
1.07M | 04/24/2024 |
$404.50 |
$406.83 |
$399.29 |
$400.76 |
806.50K | 04/25/2024 |
$402.44 |
$403.88 |
$393.00 |
$397.70 |
787.60K |
|
Vertex Pharmaceuticals is a biotechnology company. Co. has clinical and research programs to develop treatment of cystic fibrosis. In addition, Co. has a pipeline of investigational therapies in other diseases where it is utilizing insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency, and muscular dystrophies. Co.'s marketed CF medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor in combination with ivacaftor), ORKAMBI (lumacaftor in combination with ivacaftor) and KALYDECO (ivacaftor). | |
|
Vertex Pharmaceuticals (VRTX) has the following price history information. Looking back at VRTX historical stock prices for the last five trading days, on April 19, 2024, VRTX opened at $394.72, traded as high as $396.98 and as low as $391.25, and closed at $394.28. Trading volume was a total of 1.34M shares. On April 22, 2024, VRTX opened at $397.30, traded as high as $406.34 and as low as $396.00, and closed at $399.92. Trading volume was a total of 1.39M shares. On April 23, 2024, VRTX opened at $404.00, traded as high as $406.86 and as low as $403.47, and closed at $404.91. Trading volume was a total of 1.07M shares. On April 24, 2024, VRTX opened at $404.50, traded as high as $406.83 and as low as $399.29, and closed at $400.76. Trading volume was a total of 806.50K shares. On April 25, 2024, VRTX opened at $402.44, traded as high as $403.88 and as low as $393.00, and closed at $397.70. Trading volume was a total of 787.60K shares.
VRTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vertex Pharmaceuticals shares, starting with a $10,000 purchase of VRTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$67.57 |
|
End price/share: |
$397.70 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
488.57% |
|
Average Annual Total Return: |
19.40% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$58,861.63 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $394.28 | 04/22/2024 | $399.92 | 04/23/2024 | $404.91 | 04/24/2024 | $400.76 | 04/25/2024 | $397.70 |
|
|